Similarly, Li et al. revealed that CTLA-4 is overexpressed in CD166+ lung CSCs as compared to the non-CSC population isolated from primary non-small-cell lung cancer (NSCLC) tumor tissues or cell lines [69]. This evidence concerns the gene ALCAM and non-small cell lung carcinoma.